_id
6915f499bc934aba376b22c5
Ticker
SCAL
Name
Stem Cell Authority Ltd
Exchange
PINK
Address
123 South Miller Road, Fairlawn, OH, United States, 44333
Country
USA
Sector
Healthcare
Industry
Medical Care Facilities
Currency
USD
Website
https://www.stemcellauthority.com
Description
Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton's jelly inside the umbilical cord of a newborn child. The company's technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. Stem Cell Authority, Ltd. is based in Fairlawn, Ohio.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-06T10:49:23.459Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
97085
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-08-31
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
507
Operating Income
-510
Interest Expense
-
Pretax Income
-507
Net Income
-507
Eps
-5.222222215927631e-7
Dividends Per Share
-
Shares Outstanding
970851065
Income Tax Expense
-
EBITDA
-504
Operating Margin
-
Total Other Income Expense Net
3
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Bs_currency_symbol
-
Depreciation
3
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
0.02
PB
-
ROE
-
ROA
-
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
39
Deep Value Investing Score
2.5
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
1
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
0
Quality Investing Score
0
Value Investing Score
2.5
Quarters > 0 > quarter
2023-08-31
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
507
Quarters > 0 > income Statement > operating Income
-510
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-507
Quarters > 0 > income Statement > net Income
-507
Quarters > 0 > income Statement > eps
-5.222222215927631e-7
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
970851065
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-504
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
3
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
3
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-5.222222215927631e-7
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2023-05-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
507
Quarters > 1 > income Statement > operating Income
-510
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-507
Quarters > 1 > income Statement > net Income
-507
Quarters > 1 > income Statement > eps
-5.222222215927631e-7
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
970851065
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-507
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
3
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
-
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
-
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
-
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-5.222222215927631e-7
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2023-02-28
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1719
Quarters > 2 > income Statement > operating Income
-1720
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1719
Quarters > 2 > income Statement > net Income
-1719
Quarters > 2 > income Statement > eps
-0.0000017706114377080072
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
970851065
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1719
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
-
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0000017706114377080072
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2007-05-31
Quarters > 3 > income Statement > revenue
300506
Quarters > 3 > income Statement > cost Of Revenue
17172
Quarters > 3 > income Statement > gross Profit
283335
Quarters > 3 > income Statement > operating Expenses
185218
Quarters > 3 > income Statement > operating Income
115288
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
114942
Quarters > 3 > income Statement > net Income
114942
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
38.364624999168065
Quarters > 3 > income Statement > total Other Income Expense Net
-347
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
-8160
Quarters > 3 > balance Sheet > short Term Investments
48001
Quarters > 3 > balance Sheet > receivables
92649
Quarters > 3 > balance Sheet > inventories
3000
Quarters > 3 > balance Sheet > total Current Assets
150490
Quarters > 3 > balance Sheet > property Plant Equipment
87705
Quarters > 3 > balance Sheet > total Assets
2721647
Quarters > 3 > balance Sheet > payables
48041
Quarters > 3 > balance Sheet > short Term Debt
2219123
Quarters > 3 > balance Sheet > long Term Debt
2219123
Quarters > 3 > balance Sheet > total Liabilities
2267164
Quarters > 3 > balance Sheet > equity
454482
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
114942
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
25.290770591574585
Quarters > 3 > ratios > ROA
4.223251582589513
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
46
Annuals > 0 > quarter
2023-08-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
4233
Annuals > 0 > income Statement > operating Income
-4230
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-4233
Annuals > 0 > income Statement > net Income
-4233
Annuals > 0 > income Statement > eps
-0.000004360092039452004
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
970851065
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-4233
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-3
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
-
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
-
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-
Annuals > 0 > cash Flow > depreciation
-3
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
-
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.000004360092039452004
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
39
Annuals > 1 > quarter
2009-08-31
Annuals > 1 > income Statement > revenue
3327561
Annuals > 1 > income Statement > cost Of Revenue
1058975
Annuals > 1 > income Statement > gross Profit
2268586
Annuals > 1 > income Statement > operating Expenses
1495428
Annuals > 1 > income Statement > operating Income
1832133
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
1832133
Annuals > 1 > income Statement > net Income
1832133
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
55.05933625258861
Annuals > 1 > income Statement > total Other Income Expense Net
0
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
4839
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
3291335
Annuals > 1 > balance Sheet > inventories
17720
Annuals > 1 > balance Sheet > total Current Assets
3823894
Annuals > 1 > balance Sheet > property Plant Equipment
79702
Annuals > 1 > balance Sheet > total Assets
3985652
Annuals > 1 > balance Sheet > payables
1139668
Annuals > 1 > balance Sheet > short Term Debt
458000
Annuals > 1 > balance Sheet > long Term Debt
675104
Annuals > 1 > balance Sheet > total Liabilities
4077774
Annuals > 1 > balance Sheet > equity
-92121
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
1832133
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-1988.8331650763669
Annuals > 1 > ratios > ROA
45.96821297995911
Annuals > 1 > ratios > FCF
-
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
44
Annuals > 2 > quarter
2008-08-31
Annuals > 2 > income Statement > revenue
29859
Annuals > 2 > income Statement > cost Of Revenue
50234
Annuals > 2 > income Statement > gross Profit
-20375
Annuals > 2 > income Statement > operating Expenses
1416504
Annuals > 2 > income Statement > operating Income
-1386645
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-1386645
Annuals > 2 > income Statement > net Income
-1386645
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-4643.976690445092
Annuals > 2 > income Statement > total Other Income Expense Net
0
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
4334
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
17720
Annuals > 2 > balance Sheet > total Current Assets
532054
Annuals > 2 > balance Sheet > property Plant Equipment
65455
Annuals > 2 > balance Sheet > total Assets
679565
Annuals > 2 > balance Sheet > payables
737070
Annuals > 2 > balance Sheet > short Term Debt
458000
Annuals > 2 > balance Sheet > long Term Debt
139513
Annuals > 2 > balance Sheet > total Liabilities
2603817
Annuals > 2 > balance Sheet > equity
-1924251
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-1386645
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
72.06154498555541
Annuals > 2 > ratios > ROA
-204.0489136432865
Annuals > 2 > ratios > FCF
-
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
48
Annuals > 3 > quarter
2007-08-31
Annuals > 3 > income Statement > revenue
1125000
Annuals > 3 > income Statement > cost Of Revenue
351440
Annuals > 3 > income Statement > gross Profit
773561
Annuals > 3 > income Statement > operating Expenses
861183
Annuals > 3 > income Statement > operating Income
263817
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
189203
Annuals > 3 > income Statement > net Income
954203
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
-765000
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
23.4504
Annuals > 3 > income Statement > total Other Income Expense Net
-74615
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
82647
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
17721
Annuals > 3 > balance Sheet > total Current Assets
610368
Annuals > 3 > balance Sheet > property Plant Equipment
68529
Annuals > 3 > balance Sheet > total Assets
760953
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
408000
Annuals > 3 > balance Sheet > long Term Debt
39513
Annuals > 3 > balance Sheet > total Liabilities
1579504
Annuals > 3 > balance Sheet > equity
-818551
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
954203
Annuals > 3 > cash Flow > depreciation
13067
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
130278
Annuals > 3 > cash Flow > capital Expenditures
115860
Annuals > 3 > cash Flow > cash From Investing
-115860
Annuals > 3 > cash Flow > cash From Financing
109512
Annuals > 3 > cash Flow > net Change In Cash
123930
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-116.57221113895164
Annuals > 3 > ratios > ROA
125.39578659917234
Annuals > 3 > ratios > FCF
14418
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
0.012816
Annuals > 3 > health Score
36
Valuation > metrics > PE
0.02
Valuation > final Score
70
Valuation > verdict
99.8% Undervalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-170
Risk > final Score
-650
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
100
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
46
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
13
Updated At
2026-01-20T22:32:00.148Z
Earnings History > 0 > period
2023-08-31
Earnings History > 0 > report Date
2023-08-31
Earnings History > 0 > date
2023-08-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2023-05-31
Earnings History > 1 > report Date
2023-05-31
Earnings History > 1 > date
2023-05-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2023-02-28
Earnings History > 2 > report Date
2023-02-28
Earnings History > 2 > date
2023-02-28
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton's jelly inside the umbilical cord of a newborn child. The company's technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. Stem Cell Authority, Ltd. is based in Fairlawn, Ohio.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIBM offers companies a shortcut to build in-house AI assistants at scale Stock Titan
Read more āPresident Donald Trump Bans Dividends, Stock Buybacks to Push Weapons Production - ģ”°ģ ģ¼ė³“
1/8/2026
President Donald Trump Bans Dividends, Stock Buybacks to Push Weapons Production ģ”°ģ ģ¼ė³“
Read more āShowing 2 of 10
(Last Updated 2023-08-31)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ā„ 50
High ā¤ 10
* Institutions hold a combined 0.00% of the total shares of Stem Cell Authority Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
ā
EPS Estimate
ā
Date
2023-08-31
EPS Actual
0
EPS Estimate
ā
EPS Difference
0
Surprise Percent
0%
(Last Updated 2023-08-31)
(Last Updated 2023-08-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-08-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-08-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.